Compendium of Cancer Genome Aberrations

Changes

Volunteer Assignments and Opportunities (view source)

Revision as of 09:10, 28 October 2022

5,140 bytes added ,  09:10, 28 October 2022
no edit summary
Line 2,216: Line 2,216:  
|
 
|
 
|}<br />
 
|}<br />
 +
 +
==WHO Classification of Tumours of the Central Nervous System Content==
 +
{| class="wikitable"
 +
|-
 +
!'''Disease'''!!'''Page Type'''!!'''Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''!!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|Medulloblastoma, WNT-activated||Disease||Lisa Lansdon, PhD (LGG trainee just finished), Midhat Farooqi, MD (mentor), Children's Mercy Hospital Kansas City
 +
|9/20/21
 +
|
 +
|COMPLETE
 +
|
 +
|Holli Drendel (interim)/Laveniya Satgunaseelan (LS)
 +
|9/22/2022
 +
|2021 template added
 +
|-
 +
|Paediatric-Type Diffuse High-Grade Gliomas
 +
|Overview
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|2021 template added
 +
|-
 +
|Diffuse Midline Glioma, H3 K27-Altered
 +
|Disease
 +
|Laveniya Satgunaseelan (Linda Cooley - previous version)
 +
|
 +
|
 +
|PENDING
 +
|
 +
|Laveniya Satgunaseelan (LS)
 +
|
 +
|2021 template added
 +
|-
 +
|Diffuse Hemispheric Glioma, H3 G34-Mutant
 +
|Disease
 +
|Xiaolin (Lynn) Hu
 +
|2/21/2022
 +
|
 +
|PENDING
 +
|
 +
|LS
 +
|
 +
|2021 template added
 +
|-
 +
|Diffuse Paediatric-Type High-Grade Glioma, H3-Wildtype and IDH-Wildtype
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|2021 template added
 +
|-
 +
|Infant-Type Hemispheric Glioma
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|2021 template added
 +
|-
 +
|Astrocytoma, IDH-Mutant
 +
|Disease
 +
|Riley Lochner (trainee), Shashi Shetty (mentor)
 +
|3/3/2022
 +
|
 +
|PENDING
 +
|
 +
|LS
 +
|
 +
|2021 template added
 +
|-
 +
|Oligodendroglioma, IDH-Mutant and 1p/19q-Codeleted
 +
|Disease
 +
|Riley Lochner (trainee), Shashi Shetty (mentor)
 +
|3/3/2022
 +
|
 +
|PENDING
 +
|
 +
|LS
 +
|
 +
|2021 template added
 +
|-
 +
|Ganglioglioma
 +
|Disease
 +
|Leila Moayed-Aloei
 +
|6/30/2022
 +
|
 +
|PENDING
 +
|
 +
|LS
 +
|
 +
|2021 template added
 +
|-
 +
|Pilocytic Astrocytoma
 +
|Disease
 +
|Jeremy Pulvers
 +
|9/13/2022
 +
|
 +
|PENDING
 +
|
 +
|LS
 +
|
 +
|2021 template added
 +
|-
 +
|}<br />
 +
 +
==WHO Classification of Soft Tissue and Bone Tumours Content==
 +
{| class="wikitable"
 +
|-
 +
!'''Disease'''!!'''Page Type'''!!'''Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''!!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|NTRK-Rearranged Spindle Cell Neoplasm||Disease||James Solomon, MD, PhD
 +
|2/20/2022
 +
|
 +
|PENDING
 +
|
 +
|Alanna Church
 +
|
 +
|
 +
|-
 +
|}<br />
 +
 +
==WHO Classification of Tumours of Breast Tumours Content==
 +
{| class="wikitable"
 +
|-
 +
!'''Disease'''!!'''Page Type'''!!'''Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''!!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|Adenoid Cystic Carcinoma
 +
|Disease||Katherine Geiersbach
 +
|10/12/02022
 +
|
 +
|PENDING
 +
|
 +
|Hui Chen
 +
|
 +
|2021 template added
 +
|-
 +
|Secretory Carcinoma
 +
|Disease
 +
|Hui Chen
 +
|10/12/2022
 +
|
 +
|PENDING
 +
|
 +
|Katherine Geiersbach
 +
|
 +
|2021 template added
 +
|-
 +
|}<br />
 +
 +
==Gene-Specific Pages (IN PROCESS OF AUTOMATING - HOLD ON VOLUNTEERING)==
 +
{| class="wikitable sortable"
 +
!'''Gene'''
 +
!'''Author'''
 +
!'''Date Assigned to Author'''
 +
!'''Target Completion Date'''
 +
!'''Author Content (Pending or Complete)'''
 +
!'''Date Completed by Author'''
 +
!'''Associate Editor'''
 +
!'''Date of Last Editor Review'''
 +
!'''Notes'''
 +
|-
 +
|BCR
 +
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|8/10/18
 +
|
 +
|
 +
|
 +
|-
 +
|ABL1
 +
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|4/16/19
 +
|
 +
|
 +
|
 +
|-
 +
|RUNX1
 +
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|6/9/19
 +
|
 +
|
 +
|
 +
|-
 +
|RUNX1T1
 +
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|5/23/19
 +
|
 +
|
 +
|
 +
|-
 +
|MYH11
 +
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|8/6/18
 +
|
 +
|
 +
|
 +
|-
 +
|FLT3
 +
|Kay Weng Choy
 +
|
 +
|
 +
|Complete
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|NPM1
 +
|Kay Weng Choy
 +
|
 +
|
 +
|Complete
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|TP53
 +
|Kay Weng Choy
 +
|
 +
|
 +
|Complete
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|DNMT3A
 +
|Kay Weng Choy
 +
|
 +
|
 +
|Complete
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CEBPA
 +
|Gordana
 +
|
 +
|
 +
|Complete
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|IDH1
 +
|Paul De Fazio
 +
|
 +
|
 +
|Complete
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|IDH2
 +
|Paul De Fazio
 +
|
 +
|
 +
|Complete
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|PML
 +
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|12/5/18
 +
|
 +
|
 +
|
 +
|-
 +
|RARA
 +
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|8/3/18
 +
|
 +
|
 +
|
 +
|-
 +
|ETV6
 +
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|6/9/19
 +
|
 +
|
 +
|
 +
|-
 +
|KIT
 +
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|10/1/18
 +
|
 +
|
 +
|
 +
|-
 +
|CBFB
 +
|Brian Davis
 +
|
 +
|
 +
|Complete
 +
|8/2/18
 +
|
 +
|
 +
|
 +
|-
 +
|GATA2
 +
|Kay Weng Choy
 +
|
 +
|
 +
|Complete
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|PTEN
 +
|Beth Pitel
 +
|
 +
|
 +
|Pending
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|MLTT3
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|MECOM
 +
|Brian Davis
 +
|
 +
|
 +
|Pending
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|FGFR1(FLT2)
 +
|Brian Davis
 +
|
 +
|
 +
|Pending
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|KMT2A
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|DEK
 +
|Wahab A. Khan
 +
|
 +
|
 +
|Pending
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|NUP214
 +
|Wahab A. Khan
 +
|
 +
|
 +
|Pending
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|RBM15
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|MKL1
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|DDX41
 +
|Ying Zou
 +
|8/7/20
 +
|
 +
|Pending
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|ANKRD26
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CUX1
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|TET2
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|EZH2
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|FOXP1
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|MYC
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|JAK2
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|WT1
 +
|DONE
 +
|
 +
|
 +
|DONE
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CBL
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|NF1
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|SUZ12
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|ERG
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|EST2
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|RPS14
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|RB1
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|MPL
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHGA
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CDH1
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|SRSF2
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|DNMT1
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|PRDX2
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|ASXL1
 +
|DONE
 +
|
 +
|
 +
|DONE
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|MN1
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|SF3A1
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|EP300
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|JARID2
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|BRCA1
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|BRCA2
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|}
    
==WHO Central Nervous System Tumours  (5th ed.) Content==
 
==WHO Central Nervous System Tumours  (5th ed.) Content==
Line 3,317: Line 4,087:  
|-
 
|-
 
}
 
}
 +
 +
​
Retrieved from "https://ccga.io/index.php/Special:MobileDiff/11709"